Posibles indicaciones del tratamiento de las enfermedades autoinmunes con tacrolimus
Palabras clave : 
Tacrolimus
Enfermedades autoinmunes
Enfermedad inflamatoria intestinal
Inmunosupresores
Fecha de publicación: 
2004
Editorial : 
Ediciones Universidad de Navarra
ISSN: 
0556-6177
Cita: 
Sádaba B, Azanza JR, García Quetglas E, Fernández V. Posibles indicaciones del tratamiento de las enfermedades autoinmunes con tracolimus. Rev Med Univ Navarra. 2004 Jul-Sep;48(3):24-38.
Resumen
Tacrolimus is an immunosuppressive drug used most successfully as a primary drug to suppress the rejection of transplants. Tacrolimus may also be useful as a novel therapy for autoimmune disease. There are various reports in the bibliography about the use of tacrolimus in the treatment of some autoimmune diseases: inflammatory bowel disease, autoimmune hepatitis, cutaneous, neurologic, renal, endocrine or eye disease. In this review of more than 130 papers, we discuss the rationale for the use of tacrolimus in autoimmune disease and report the clinical experience with the drug in the management of a variety of autoimmune diseases. But, although there are a lot questions that require future research (dose, duration of treatment, when to begin tacrolimus treatment, how to monitor it, etc.), there is also wide experience with tacrolimus in the treatment of this type of disease.

Ficheros en este registro:
Fichero: 
Rev Med Univ Navarra 2004 pag 24-38[1].pdf
Descripción: 
Tamaño: 
164,36 kB
Formato: 
Adobe PDF


Los ítems de Dadun están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.